FindTrial
Sign In

Efficacy of Ara-C and GCSF for hematopoietic stem cell mobilization compared to other regimen in Autologous stem cell transplantation patients in bone marrow transplantation unit of non-medical school center in Thailand

Efficacy of Ara-C and GCSF for hematopoietic stem cell mobilization compared to other regimen in Autologous stem cell transplantation patients in bone marrow transplantation unit of non-medical school center in Thailand

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20260203002
Enrollment
68
Registered
2026-02-03
Start date
2025-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple myeloma and Lymphoma patients who received autologous stem cell transplantation Hematopoietic stem cell mobilization, Ara-C and G-CSF, Autologous stem cell transplantation in non-medical school center, Thailand

Interventions

The patients who received mobilization Ara-C regimen,The patients who received mobilization other regimen accept Ara-C
Treatment,Treatment
Group Ara C,Group non Ara C

Sponsors

Chonburi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients aged at and more than 18 years. 2.Undergoing autologous stem cell transplantation. 3.Received mobilization regimens using Ara-C or other formulas

Exclusion criteria

Exclusion criteria: 1.Patients with failed stem cell mobilization or collection.

Design outcomes

Primary

MeasureTime frame
Efficacy of mobilization 1 day total CD34 count cell/kg—

Secondary

MeasureTime frame
Neutrophil engraftment 30 day day,Platelet engraftment 30 day day—

Countries

Thailand

Contacts

Public ContactPenpun Piwbuakum

Chonburi hospital

chosnd@gmail.com0871535838

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026